 |
|
|
 |
- A Phase I Trial of Doxorubicin and Flavopiridol in the Treatment of Metastatic Sarcoma
D'Adamo, David, MD
[Protocol 04-075]
- A Phase II Study of Five-Year Imatinib (Gleevec®) in Patients at Significant Risk for Recurrence of Primary Gastrointestinal Stromal Tumor
DeMatteo, Ronald, MD
[Protocol 09-061]
- A Phase II Study of Trabectedin in Children with Recurrent Rhabdomyosarcoma, Ewing's Sarcoma, or Nonrhabdomyosarcomatous Sarcomas
Wexler, Leonard, MD
[Protocol 08-145]
- A Phase II Trial of Irinotecan plus Carboplatin, and Irinotecan Maintenance Therapy Integrated into the Upfront Therapy of Newly Diagnosed Patients with Intermediate- and High-Risk Rhabdomyosarcoma
Wexler, Leonard, MD
[Protocol 03-099]
- A Phase II Trial of R1507 for People with Recurrent Sarcoma
Maki, Robert, MD
[Protocol 07-166]
- A Phase II Trial of Sorafenib and Dacarbazine in Soft-Tissue Sarcoma
D'Adamo, David, MD
[Protocol 08-068]
- A Randomized Phase II Trial of Gemcitabine and Docetaxel with or without Bevacizumab in Leiomyosarcoma, Malignant Fibrous Histiocytoma, and Angiosarcoma
D'Adamo, David, MD
[Protocol 09-015]
- A Study of SCH 717454 in Patients with Osteosarcoma or Ewing's Sarcoma That Has Relapsed After Standard Systemic Therapy
Meyers, Paul, MD
[Protocol 08-134]
- Vincristine, Dactinomycin, and Lower Doses of Cyclophosphamide in Patients with Newly Diagnosed Low-Risk Embryonal/Botryoid Rhabdomyosarcoma
Wexler, Leonard, MD
[Protocol 05-032]
|
|
|
|
|
